Is a complete TNDM research report available?

No complete published report is available for Tandem Diabetes Care, Inc. (TNDM) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Tandem Diabetes Care, Inc. (TNDM)

NASDAQ: TNDM · USD

$18.6

+0.83 (+4.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first TNDM analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.3B
Revenue (ttm)	1B
Net income (ttm)	-94.5M
EPS (ttm)	-$1.39
Shares out	68.5M
Volume	1,910,948
Beta	1.58
Price target	$28.5	+53.5%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1B
Net income (ttm): -94.5M
EPS (ttm): -$1.39
Market cap: 1.3B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All TNDM indicators

Market & fundamental data

Available fields

229

Groups with data

Currency

USD

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001438133
Company name	Tandem Diabetes Care, Inc.
Country	United States
Country code	US
Cusip	875372203
Employees	2,500
Employees Change	-150%
Employees Change Percent	-5.66
Enterprise value	$1.4B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Industry PE	40.96
Industry PE Fwd	19.8
IPO Date	2013-11-14
Isin	US8753722037
Last refreshed	2026-07-30
Market cap	$1.3B
Market cap category	Small-Cap
Price	$18.59
Price currency	USD
Rev Per Employee	411,014x
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	3841
Symbol	TNDM
Website	https://www.tandemdiabetes.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.39%
EV Sales Forward	1.31x
EV/Sales	1.4x
FCF yield	-0.28%
P/B ratio	9.19x
P/S ratio	1.24x
PS Forward	1.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-8.16%
EBITDA Margin	-6.42%
Gross margin	54.93%
Gross Profit	$564.4M
Gross Profit Growth	9.95%
Gross Profit Growth Q	15.52%
Gross Profit Growth3 Y	11.72%
Gross Profit Growth5 Y	14.76%
Net Income	$-94.5M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-9.54%
Profit Margin	-9.2%
Profit Per Employee	$-37,819
ROA	-3.68
Roa5y	-4.54
ROCE	-9.26
ROE	-65.73
Roe5y	-41.61
ROIC	-20.06
Roic5y	-25.83

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-13.34%
Cagr1y	10.4%
Cagr3y	-19.52%
Cagr5y	-29.21%
EPS Growth Quarters	1
EPS Growth Years	0
OCF Growth	40.65%
OCF Growth3 Y	2.26%
OCF Growth5 Y	-23.32%
Revenue Growth	4.54x
Revenue Growth Q	5.46x
Revenue Growth Quarters	9x
Revenue Growth Years	2x
Revenue Growth3 Y	8.94x
Revenue Growth5 Y	13.65x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.99
Assets	$1.2B
Cash	$570.3M
Current Assets	$887.1M
Current Liabilities	$248M
Debt	$734.7M
Debt Equity	$5.55
Equity	$132.4M
Interest Coverage	-10.16
Liabilities	$1B
Long Term Assets	$266.3M
Long Term Liabilities	$773M
Net Cash	$-164.5M
Net Cash By Market Cap	$-12.86
Net Debt Equity	$1.24
Tangible Book Value	$132.4M
Tangible Book Value Per Share	$1.93
WACC	8.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.58
Inventory Turnover	3.46
Net Working Capital	$89M
Quick ratio	2.87
Working Capital	$639.1M
Working Capital Turnover	$2.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.14%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-76.11%
1Y total return	10.39%
200-day SMA	18.96
3Y total return	-47.88%
50-day SMA	16.3
50-day SMA vs 200-day SMA	50under200
5Y total return	-82.22%
All Time High	302.5
All Time High Change	-93.85%
All Time High Date	2014-01-14
All Time Low	2.14
All Time Low Change	768.69%
All Time Low Date	2018-02-09
ATR	1.03
Beta	1.58
Beta1y	-0.75
Beta2y	0.59
Ch YTD	-15.42
High	18.75
High52	29.65
High52 Date	2026-02-24
High52ch	-37.3%
Low	17.42
Low52	9.98
Low52 Date	2025-08-07
Low52ch	86.27%
Ma50ch	14.05%
Premarket Change Percent	0
Premarket Price	$17.76
Premarket Volume	3,314
Price vs 200-day SMA	-1.94%
RSI	64.07
RSI Monthly	44.43
RSI Weekly	50.74
Sharpe ratio	0.46x
Sortino ratio	0.83
Total Return	-3.14%
Tr YTD	-15.42
Tr1m	14.47%
Tr1w	9.94%
Tr3m	-0.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	23
Analyst Count Top	4
Analyst Price Target Top	$25.25
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.33
Earnings Revenue Estimate	254,971,768x
Earnings Revenue Estimate Growth	5.94x
Operating Income	$-61.1M
Operating margin	-5.94
Price target	$28.53
Price Target Change	$53.47
Price Target Change Top	$35.83

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	62,919,987%
Float Percent	91.82%
Net Borrowing	259,240,000
Shares Insiders	1.26%
Shares Institutions	109.43%
Shares Out	68,529,089
Shares Qo Q	0.56%
Shares Yo Y	3.14%
Short Float	20.84%
Short Ratio	6.9
Short Shares	19.14

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-86.2M
Adjusted OCF	-62,941,000
Average Volume	1,604,081.35x
Bv Per Share	1.93
CAPEX	$-23.3M
Ch10y	-76.11
Ch1m	14.47
Ch1w	9.94
Ch1y	10.39
Ch3m	-0.21
Ch3y	-47.88
Ch5y	-82.22
Ch6m	-2.72
Change	4.67%
Change From Open	4.5
Close	17.76
Days Gap	0.17
Depreciation Amortization	17,859,000
Dollar Volume	35,524,523.3
Earnings Date	2026-08-06
Earnings Time	amc
EBIT	$-83.8M
EBITDA	$-66M
EPS	$-1.39
F Score	4
FCF	$-3.6M
FCF EV Yield	-0.25x
FCF Per Share	$-0.05
Financing CF	235,482,000
Fiscal Year End	December
Founded	2,006
Income Tax	$-3.5M
Investing CF	-131,758,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2017-10-10
Last Split Type	Reverse
Last10k Filing Date	2026-02-19
Ma150	19.29
Ma150ch	-3.64%
Ma20	16.42
Ma20ch	13.19%
Net CF	125,751,000
Next Earnings Date	2026-08-06
Open	17.79
Optionable	Yes
P OCF Ratio	65.21
Position In Range	87.97
Post Close	18.59
Postmarket Change Percent	-2.04
Postmarket Price	$18.21
Ppne	178,990,000
Pre Close	17.76
Price Date	2026-07-29
Ptbv Ratio	9.66
Relative Volume	1.19x
Revenue	1,027,535,000x
SBC By Revenue	8.03x
Share Based Comp	82,552,000
Tax By Revenue	-0.34x
Tr6m	-2.72%
Us State	California
Volume	1,910,948
Z Score	0.56

Tandem Diabetes Care, Inc. (TNDM)

Coverage state: Market snapshot only — no published research

Generate the first TNDM analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · TNDM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TNDM indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on TNDM

Frequently asked questions